Predictors of response and survival in patients with unresectable hepatocellular carcinoma treated with nivolumab: real-world experience

Real-world predictors of the treatment efficacy of immune checkpoint inhibitors for hepatocellular carcinoma (HCC) are unknown. This retrospective study enrolled 87 consecutive patients with unresectable HCC from May 2017 to December 2019 at two hospitals. Of the 87 patients, 7, 9, 60, and 11 patien...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Am J Cancer Res
Glavni autori: Hsu, Wei-Fan, Chuang, Po-Heng, Chen, Cheng-Kuo, Wang, Hung-Wei, Tsai, Ming-Hung, Su, Wen-Pang, Chen, Hung-Yao, Yang, Chi-Ying, Lin, Chun-Che, Huang, Guan-Tarn, Lin, Jaw-Town, Lai, Hsueh-Chou, Peng, Cheng-Yuan
Format: Artigo
Jezik:Inglês
Izdano: e-Century Publishing Corporation 2020
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7783753/
https://ncbi.nlm.nih.gov/pubmed/33415018
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items